Brought to you by:
First patient enrolled in HERCULES randomized trial comparing ESAR and EVAR
The first patient has been enrolled into the HERCULES trial, which compares endosuture aneurysm repair (ESAR) to standard endovascular aneurysm repair (EVAR) in the treatment of abdominal aortic aneurysms (AAAs) with wide proximal necks. HERCULES is an investigator-driven trial led by Michel Reijnen, MD,…
First US patient enrolled in SOCRATES short neck AAA trial
The first U.S. patient has been treated as part of the SOCRATES trial (Short neck AAA randomized trial—ESAR and FEVAR), which compares the safety and performance of endosuture aneurysm repair (ESAR) with fenestrated endovascular aneurysm repair (FEVAR) for the treatment…
Short neck AAAs: ‘Choosing what is best for the patient’
Navigating cases of abdominal aortic aneurysm (AAA) with short neck anatomy poses a serious challenge to vascular surgeons, but the list of potential options available to carry out repairs are numerous—and decision-making can be optimized by using a bespoke algorithm.…
Five-year outcomes of ESAR in patients with short neck
Cohort analysis shows no migrations, a low rate of ruptures, and positive sac regression, researchers say. Five-year outcomes in patients with short neck abdominal aortic aneurysms (AAAs) undergoing endosuture aneurysm repair (ESAR) using Heli-FX EndoAnchors with an Endurant stent-graft in…
VAM: Spotlight on Thursday
It’s Thursday and the Vascular Annual Meeting is in full swing. Here are some sessions today for you to consider, including the first Presidential Address in a double-header of speeches. 6:30 to 8 a.m. Feed your body and your brain at…
VAM: Industry-sponsored symposia
Industry-sponsored symposia at the Vascular Annual Meeting (VAM) will be presented Wednesday and Thursday evenings and at three breakfast sessions taking place Thursday morning. Industry-supported evening Satellite Symposia will be held from 6:30 to 8 p.m. Wednesday and Thursday. Wednesday’s…